共 50 条
- [25] Editorial: Minimal residual disease (MRD) assessment in multiple myeloma patients FRONTIERS IN ONCOLOGY, 2023, 13
- [26] Clinical relevance of Minimal residual Disease assessment by NGS in Multiple Myeloma CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E179 - E180
- [27] Post-transplant minimal residual disease assessment in Multiple myeloma CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E180 - E180
- [30] The role of CD44 in the assessment of minimal residual disease of multiple myeloma by flow cytometry Journal of Hematopathology, 2021, 14 : 299 - 307